MktsMarkets

Arrowhead Pharmaceuticals, Inc.
NASDAQ: ARWRKey statistics
ARWR News
Stories mentioning ARWR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 73,737 | 264,033 | 256,472 | 27,767 | 542,709 | 2,500 | 0.00 | 0.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 173,253 | 177,203 | 133,102 | 137,002 | ||||
| Sales General & Admin | 41,744 | 28,405 | ||||||
| Total Operating Expenses | 214,997 | 223,224 | 212,366 | 193,317 | 161,507 | 163,912 | 162,203 | 176,141 |
| Operating Income (Loss) | (141,260) | 40,809 | 44,106 | (165,550) | 381,202 | (161,412) | (162,203) | (176,141) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1,609) | 277.00 | 4,656 | (176.00) | 438.00 | 341.00 | (3,118) | 760.00 |
| Pretax Income | (137,565) | 28,271 | 36,121 | (179,089) | 369,616 | (175,115) | (172,798) | (173,977) |
| Tax Provision | 7.00 | 29.00 | 20,000 | (437.00) | 1,753 | 103.00 | 546.00 | 0.00 |
| Net Income (Loss) | (132,732) | 30,811 | (23,750) | (175,241) | 370,445 | (173,085) | (170,536) | (170,793) |
| Earnings Per Share (Basic) | (0.93) | 0.22 | (0.18) | (1.26) | 2.78 | (1.39) | (1.42) | (1.38) |
| Earnings Per Share (Diluted) | (0.93) | 0.22 | (0.18) | (1.26) | 2.75 | (1.39) | (1.42) | (1.38) |
| Weighted Average Shares Outstanding (Basic) | 142,417 | 137,039 | 133,758 | 139,039 | 133,363 | 124,848 | 119,784 | 124,199 |
| Weighted Average Shares Outstanding (Diluted) | 142,417 | 140,706 | 133,758 | 139,039 | 134,484 | 124,848 | 119,784 | 124,199 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ARWR
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARWR. It last traded at $49.24 (Nov 9, 2026, 4:00 PM ET), down 15.3% on the day. That gives Arrowhead Pharmaceuticals a market capitalisation of $6.7B.
Over the past 52 weeks ARWR has traded between $37.06 and $95.49.
Revenue for the quarter ended Mar 31, 2026 was $73.7M; a net loss of $132.7M. Revenue was down 86.4% from $542.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $73.7M | -$132.7M | -180.0% |
| Dec 31, 2025 | $264.0M | $30.8M | 11.7% |
| Sep 30, 2025 | $256.5M | -$23.8M | -9.3% |
| Jun 30, 2025 | $27.8M | -$175.2M | -631.1% |
From Arrowhead Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…